2:00 PM - 2:15 PM, Thursday, June 6, 2019 ・ Theater 2
DARC Technology combines a biomarker with an AI algorithm to de-risk clinical development, improving study outcomes whilst reducing time to market & costs for glaucoma & AMD therapeutics. We are ILLUSTRATUM, a British biotechnology company who are commercialising DARC Technology, developed by Professor M Francesca Cordeiro through Wellcome Trust funding. Francesca Cordeiro is a Professor at UCL Institute of Ophthalmology and Imperial College London and is Director of the clinical trials unit at The Western Eye Hospital.
Not Provided.
Not Provided.
Company Type:
Company Website:
Company HQ State:
Not Provided.
Company HQ Country:
United Kingdom
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
DARC Technology Biomarker
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided.
Chief Executive Officer